Doctor profile · Federal record
Dr. Luke Dreisbach, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Rancho Mirage, CA
- NPI 1831109792
- Accepts Medicare
- MIPS 82.1 / 100 · 2023
- 32 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
34490 Bob Hope Dr.
Rancho Mirage, CA 922700000
(760) 568-3613
fax (760) 340-5189 - Additional location
-
39800 Bob Hope Dr, Ste C
Rancho Mirage, CA 922703920
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- May 28, 2020
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A70978
- Medicaid
- CA #00A709780
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831109792. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
824,645
Distinct HCPCS
10
Medicare allowed
$12,383,809
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 249,750 | 165 | $1 | |
J0641 |
Injection, levoleucovorin, not otherwise specified, 0.5 mg | 118,300 | 24 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 84,506 | 51 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 65,850 | 97 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 45,000 | 303 | $23 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 30,240 | 91 | $7 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 29,800 | 22 | $12 | |
J9299 |
Injection, nivolumab, 1 mg | 26,100 | 15 | $30 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 25,920 | 14 | $47 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 18,700 | 17 | $0 |
In context: peer comparison
Among 8 peers in Rancho Mirage Hematology & Oncology Physician, average services per provider: 5,587. This provider delivers 148× the peer median.Open Payments
Industry payments received
All-time total
$3,581
Transactions
118
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Pfizer INC. | 14 | $283.23 | |
| AstraZeneca Pharmaceuticals Lp | 10 | $254.45 | |
| Novartis Pharmaceuticals Corporation | 13 | $238.90 | |
| Janssen Biotech, INC. | 11 | $177.94 | |
| E.R. Squibb & Sons, L.L.C. | 17 | $176.80 | |
| BeiGene USA, INC. | 6 | $163.48 | |
| Daiichi Sankyo INC. | 6 | $151.88 | |
| GlaxoSmithKline, LLC. | 9 | $136.32 | |
| Regeneron Healthcare Solutions, INC. | 4 | $125.81 | |
| Gilead Sciences, INC. | 5 | $117.78 | |
| Astellas Pharma US INC | 5 | $117.35 | |
| Celgene Corporation | 4 | $113.56 | |
| Merck Sharp & Dohme LLC | 5 | $104.18 | |
| Abbvie INC. | 5 | $99.68 | |
| Tempus Ai, INC | 4 | $94.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
856
Patients
207
Total drug cost
$3,702,180
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 139 | 61 | $4,396 |
| Ibrance (Palbociclib) | Brand | 88 | 12 | $1,255,774 |
| Letrozole | Generic | 69 | 24 | $5,252 |
| Ondansetron Hcl | Generic | 67 | 37 | $648 |
| Revlimid (Lenalidomide) | Brand | 64 | 0 | $1,179,447 |
| Hydroxyurea | Generic | 56 | 22 | $1,993 |
| Dexamethasone | Generic | 55 | 16 | $621 |
| Prednisone | Generic | 55 | 20 | $518 |
| Imatinib Mesylate | Generic | 48 | 0 | $61,798 |
| Abiraterone Acetate | Generic | 46 | 0 | $264,430 |
Hospital affiliations
Frequently asked questions
What is Dr. Luke Dreisbach's medical specialty?
Dr. Luke Dreisbach practices Hematology & Oncology Physician in Rancho Mirage, CA.
Where does Dr. Luke Dreisbach practice?
Dr. Luke Dreisbach practices at 34490 Bob Hope Dr., Rancho Mirage, CA 922700000. Office phone: 7605683613.
What is Dr. Luke Dreisbach's NPI?
Dr. Luke Dreisbach's National Provider Identifier (NPI) is 1831109792, issued by NPPES.
Does Dr. Luke Dreisbach accept Medicare assignment?
Yes. Dr. Luke Dreisbach accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Luke Dreisbach commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, levoleucovorin, not otherwise specified, 0.5 mg (HCPCS J0641); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.